Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma

Amanda Walker, Alin Chirindel, Robert Hobbs, Minh Phuong Huynh-Le, Joseph A. Moore, Steve Y. Cho, Stephanie A Terezakis

Research output: Contribution to journalArticle

Abstract

Purpose: A limitation of [18F] 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDGPET) in radiation planning for Hodgkin lymphoma (HL) is significant variability in delineation of tumor volume. One approach to reduce variability is to apply automatic or semiautomatic segmentation methods such as thresholding based on a percent tumor maximum standardized uptake value (SUVmax). Here, we apply various tumor SUVmax thresholds and examine their effects in involved field radiation therapy (IFRT) and involved site radiation therapy (ISRT) target volumes. Methods and materials: PET/computed tomography data sets were reviewed for 16 pediatric and young adult patients treated with IFRT. The following percent tumor SUVmax thresholds were applied to the prechemotherapy PET: 15%, 20%, 25%, 30%, 35%, and 40%. Clinical target volumes for IFRT and ISRT plans were manually generated based on these threshold volumes (CTVPET) and compared with clinical target volumes generated using the standard qualitative visual method (CTVQVM). Treatment plans were generated, doses to normal structures were compared, and the optimum threshold, defined as the CTVPET that corresponded to the percent overlap closest to 100% when compared with the CTVQVM, was determined. Results: On average, there was a 7.6-fold increase in PET volume between 40% and 15% SUVmax. When the 6 SUVmax thresholds were applied in the design of target volumes for IFRT, 2 of 16 patients had a change in treatment volume. There was a 2.4-fold increase in ISRT CTVs generated based on the 15% and 40% SUVmax, which translated into a clinically significant decrease in dose to normal structures when the ISRT plans that were generated using the 15% SUVmax volumes were compared with the 40% SUVmax. In most patients, the optimum threshold was SUVmax 15%. Conclusions: Accurate target volume delineation with [18F] 2-fluoro-2-deoxy-d-glucose PET in HL is challenging and may require more precise and reproducible segmentation methods as we move toward more conformal therapies.

Original languageEnglish (US)
Pages (from-to)219-227
Number of pages9
JournalPractical Radiation Oncology
Volume5
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Hodgkin Disease
Radiotherapy
Pediatrics
Glucose
Neoplasms
Tumor Burden
Positron-Emission Tomography
Young Adult
Therapeutics
Tomography
Radiation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma. / Walker, Amanda; Chirindel, Alin; Hobbs, Robert; Huynh-Le, Minh Phuong; Moore, Joseph A.; Cho, Steve Y.; Terezakis, Stephanie A.

In: Practical Radiation Oncology, Vol. 5, No. 4, 2015, p. 219-227.

Research output: Contribution to journalArticle

Walker, Amanda ; Chirindel, Alin ; Hobbs, Robert ; Huynh-Le, Minh Phuong ; Moore, Joseph A. ; Cho, Steve Y. ; Terezakis, Stephanie A. / Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma. In: Practical Radiation Oncology. 2015 ; Vol. 5, No. 4. pp. 219-227.
@article{44627cd2a6764d9e9ca4d2c4f4b16719,
title = "Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma",
abstract = "Purpose: A limitation of [18F] 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDGPET) in radiation planning for Hodgkin lymphoma (HL) is significant variability in delineation of tumor volume. One approach to reduce variability is to apply automatic or semiautomatic segmentation methods such as thresholding based on a percent tumor maximum standardized uptake value (SUVmax). Here, we apply various tumor SUVmax thresholds and examine their effects in involved field radiation therapy (IFRT) and involved site radiation therapy (ISRT) target volumes. Methods and materials: PET/computed tomography data sets were reviewed for 16 pediatric and young adult patients treated with IFRT. The following percent tumor SUVmax thresholds were applied to the prechemotherapy PET: 15{\%}, 20{\%}, 25{\%}, 30{\%}, 35{\%}, and 40{\%}. Clinical target volumes for IFRT and ISRT plans were manually generated based on these threshold volumes (CTVPET) and compared with clinical target volumes generated using the standard qualitative visual method (CTVQVM). Treatment plans were generated, doses to normal structures were compared, and the optimum threshold, defined as the CTVPET that corresponded to the percent overlap closest to 100{\%} when compared with the CTVQVM, was determined. Results: On average, there was a 7.6-fold increase in PET volume between 40{\%} and 15{\%} SUVmax. When the 6 SUVmax thresholds were applied in the design of target volumes for IFRT, 2 of 16 patients had a change in treatment volume. There was a 2.4-fold increase in ISRT CTVs generated based on the 15{\%} and 40{\%} SUVmax, which translated into a clinically significant decrease in dose to normal structures when the ISRT plans that were generated using the 15{\%} SUVmax volumes were compared with the 40{\%} SUVmax. In most patients, the optimum threshold was SUVmax 15{\%}. Conclusions: Accurate target volume delineation with [18F] 2-fluoro-2-deoxy-d-glucose PET in HL is challenging and may require more precise and reproducible segmentation methods as we move toward more conformal therapies.",
author = "Amanda Walker and Alin Chirindel and Robert Hobbs and Huynh-Le, {Minh Phuong} and Moore, {Joseph A.} and Cho, {Steve Y.} and Terezakis, {Stephanie A}",
year = "2015",
doi = "10.1016/j.prro.2014.12.004",
language = "English (US)",
volume = "5",
pages = "219--227",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma

AU - Walker, Amanda

AU - Chirindel, Alin

AU - Hobbs, Robert

AU - Huynh-Le, Minh Phuong

AU - Moore, Joseph A.

AU - Cho, Steve Y.

AU - Terezakis, Stephanie A

PY - 2015

Y1 - 2015

N2 - Purpose: A limitation of [18F] 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDGPET) in radiation planning for Hodgkin lymphoma (HL) is significant variability in delineation of tumor volume. One approach to reduce variability is to apply automatic or semiautomatic segmentation methods such as thresholding based on a percent tumor maximum standardized uptake value (SUVmax). Here, we apply various tumor SUVmax thresholds and examine their effects in involved field radiation therapy (IFRT) and involved site radiation therapy (ISRT) target volumes. Methods and materials: PET/computed tomography data sets were reviewed for 16 pediatric and young adult patients treated with IFRT. The following percent tumor SUVmax thresholds were applied to the prechemotherapy PET: 15%, 20%, 25%, 30%, 35%, and 40%. Clinical target volumes for IFRT and ISRT plans were manually generated based on these threshold volumes (CTVPET) and compared with clinical target volumes generated using the standard qualitative visual method (CTVQVM). Treatment plans were generated, doses to normal structures were compared, and the optimum threshold, defined as the CTVPET that corresponded to the percent overlap closest to 100% when compared with the CTVQVM, was determined. Results: On average, there was a 7.6-fold increase in PET volume between 40% and 15% SUVmax. When the 6 SUVmax thresholds were applied in the design of target volumes for IFRT, 2 of 16 patients had a change in treatment volume. There was a 2.4-fold increase in ISRT CTVs generated based on the 15% and 40% SUVmax, which translated into a clinically significant decrease in dose to normal structures when the ISRT plans that were generated using the 15% SUVmax volumes were compared with the 40% SUVmax. In most patients, the optimum threshold was SUVmax 15%. Conclusions: Accurate target volume delineation with [18F] 2-fluoro-2-deoxy-d-glucose PET in HL is challenging and may require more precise and reproducible segmentation methods as we move toward more conformal therapies.

AB - Purpose: A limitation of [18F] 2-fluoro-2-deoxy-d-glucose positron emission tomography (FDGPET) in radiation planning for Hodgkin lymphoma (HL) is significant variability in delineation of tumor volume. One approach to reduce variability is to apply automatic or semiautomatic segmentation methods such as thresholding based on a percent tumor maximum standardized uptake value (SUVmax). Here, we apply various tumor SUVmax thresholds and examine their effects in involved field radiation therapy (IFRT) and involved site radiation therapy (ISRT) target volumes. Methods and materials: PET/computed tomography data sets were reviewed for 16 pediatric and young adult patients treated with IFRT. The following percent tumor SUVmax thresholds were applied to the prechemotherapy PET: 15%, 20%, 25%, 30%, 35%, and 40%. Clinical target volumes for IFRT and ISRT plans were manually generated based on these threshold volumes (CTVPET) and compared with clinical target volumes generated using the standard qualitative visual method (CTVQVM). Treatment plans were generated, doses to normal structures were compared, and the optimum threshold, defined as the CTVPET that corresponded to the percent overlap closest to 100% when compared with the CTVQVM, was determined. Results: On average, there was a 7.6-fold increase in PET volume between 40% and 15% SUVmax. When the 6 SUVmax thresholds were applied in the design of target volumes for IFRT, 2 of 16 patients had a change in treatment volume. There was a 2.4-fold increase in ISRT CTVs generated based on the 15% and 40% SUVmax, which translated into a clinically significant decrease in dose to normal structures when the ISRT plans that were generated using the 15% SUVmax volumes were compared with the 40% SUVmax. In most patients, the optimum threshold was SUVmax 15%. Conclusions: Accurate target volume delineation with [18F] 2-fluoro-2-deoxy-d-glucose PET in HL is challenging and may require more precise and reproducible segmentation methods as we move toward more conformal therapies.

UR - http://www.scopus.com/inward/record.url?scp=84937112769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937112769&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2014.12.004

DO - 10.1016/j.prro.2014.12.004

M3 - Article

C2 - 26146182

AN - SCOPUS:84937112769

VL - 5

SP - 219

EP - 227

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

IS - 4

ER -